Form 4: Charles River Laboratories Executive Shannon M. Parisotto Reports Stock Sales and Share Transfer

Shannon M. Parisotto, CEVP at Charles River Laboratories, reports selling shares and receiving a share transfer.

Summary

• Shannon M. Parisotto, a CEVP at Charles River Laboratories International, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 29, 2024, Parisotto sold 3,686 shares of common stock at a weighted average price of $253.43, with prices ranging from $252.99 to $253.87.
• An additional 100 shares were sold on the same day at $254.02.
• On March 1, 2024, Parisotto received 2,440 shares through an exempt transfer from Karpathos Investments LLC, increasing indirect ownership.
• Following these transactions, Parisotto directly owns 7,132 shares and indirectly owns 26,554 shares through Karpathos Investments LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The sale of shares could be seen as slightly negative, but the transfer of shares is a positive.

Positives

• The receipt of 2,440 shares via an exempt transfer from Karpathos Investments LLC increases Parisotto's indirect ownership.

Negatives

• The sale of 3,786 shares by Parisotto may be viewed negatively by some investors.

Risks

• Executive stock sales can sometimes be interpreted as a lack of confidence in the company's future performance, although this is not always the case.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are regularly monitored by investors for insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Executive compensation and stock ownership structures vary across the pharmaceutical and biotechnology industries.
• Comparing Parisotto's transactions to those of executives at companies like Labcorp (LH), Quest Diagnostics (DGX), or Envista (NVST) could provide a benchmark, but would require further research into their individual filings and compensation packages.
• Without additional context on Parisotto's overall compensation and stock holdings, it's difficult to assess whether these transactions are typical or unusual compared to industry peers.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be negligible.

Key Dates